adUnits.push({
code: ‘Rpp_mundo_actualidad_Nota_Interna1’,
mediaTypes: {
banner: {
sizes: (navigator.userAgent.match(/iPhone|android|iPod/i)) ? [[300, 250], [320, 460], [320, 480], [320, 50], [300, 100], [320, 100]] : [[300, 250], [320, 460], [320, 480], [320, 50], [300, 100], [320, 100], [635, 90]]
}
},
bids: [{
bidder: ‘appnexus’,
params: {
placementId: ‘14149971’
}
},{
bidder: ‘rubicon’,
params: {
accountId: ‘19264’,
siteId: ‘314342’,
zoneId: ‘1604128’
}
},{
bidder: ‘amx’,
params: {
tagId: ‘MTUybWVkaWEuY29t’
}
},{
bidder: ‘oftmedia’,
params: {
placementId: navigator.userAgent.match(/iPhone|android|iPod/i) ? ‘22617692’: ‘22617693’
}
}]
});
The UK on Monday became the first country to approve Moderna’s bivalent vaccine, developed to fight the original COVID-19 virus and a new variant of omicron, the Medicines and Health Products Regulatory Agency (MHRA) said in English.
Based on this decision, the vaccine is expected to be used as a booster vaccine in the coming fall, although the number of doses available is currently unknown.
Health authorities have already indicated that starting next September, the booster vaccine will be offered to people over 50 and people in the highest risk groups.
The original vaccines used during the pandemic were developed to fight the original form of the virus that emerged in Wuhan, China in late 2019, but the virus has since mutated as new variants have emerged that can elude the immune system, causing triggered outbreaks. COVID-19 in many countries.
Once a year
With this bivalent vaccine, adults are expected to only need one injection once a year.
The dose, known as mRNA-1273.214, is an updated version of the vaccine. modern which is already given as the first, second and booster doses and is now becoming the approved dose in United Kingdom which targets two strains of the virus.
According to the MHRA, the side effects from the vaccine are the same as the original booster dose of Moderna and were generally mild.
MHRA Executive Director June Rein called the new reinforcement “the sharpest tool in our arsenal” for defense United Kingdom against COVID-19.
“I am pleased to announce the approval of a bivalent booster vaccine. modern“To “provide a strong immune response against the Omicron BA.1 variant as well as the original 2020 strain,” Rein added.
new generation vaccine
Medical Director Mr. modernPaul Burton said the new vaccine could raise a person’s antibody levels to such a high level that they might only be needed once a year.
Stephan Bansel, CEO of Moderna, described it as “a vaccine against COVID-19 generation” that will play “an important role in protecting people in United Kingdom against COVID-19″in winter.
“We are very pleased to receive MHRA approval for Spikevax Bivalent Original/Omicron, our vaccine. COVID-19 the next generation,” Bansel stressed in the media.
“This is the first approval for a bivalent vaccine containing Omicron, which once again highlights the commitment and leadership of public health authorities in United Kingdom to help end the pandemic COVID-19″, he added.
(As reported by EFE)
OUR PODCASTS
“Espacio Vital”: Dr. Leslie Soto, infectious disease doctor at the Cayetano Heredia Hospital, answered calls from listeners about monkeypox. Thus, he dispelled many doubts and myths about this disease, which can be infected by any person if he does not follow biosecurity protocols and protective measures.
Source: RPP
I’m Liza Grey, an experienced news writer and author at the Buna Times. I specialize in writing about economic issues, with a focus on uncovering stories that have a positive impact on society. With over seven years of experience in the news industry, I am highly knowledgeable about current events and the ways in which they affect our daily lives.